Pages that link to "Q34358286"

The following pages link to Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer (Q34358286):

Displaying 23 items.

• TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers (Q24288715) (← links)
• Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease (Q24289344) (← links)
• CpG island methylation in colorectal cancer: past, present and future (Q24597977) (← links)
• Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum (Q28262150) (← links)
• A genome-wide DNA methylation study in colorectal carcinoma (Q31020320) (← links)
• Promoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients (Q35034717) (← links)
• Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803 (Q35729861) (← links)
• Molecular analysis of colorectal tumors within a diverse patient cohort at a single institution (Q35737549) (← links)
• Comparative Correlation Structure of Colon Cancer Locus Specific Methylation: Characterisation of Patient Profiles and Potential Markers across 3 Array-Based Datasets (Q35856869) (← links)
• Colorectal cancer: a tale of two sides or a continuum? (Q35935945) (← links)
• No evidence for interference of h&e staining in DNA testing: usefulness of DNA extraction from H&E-stained archival tissue sections. (Q36059870) (← links)
• Epigenetics and colorectal cancer (Q36081553) (← links)
• LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer. (Q36414307) (← links)
• Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors. (Q36463826) (← links)
• Biomarker use in colorectal cancer therapy (Q36968539) (← links)
• Epigenetics and colorectal cancer pathogenesis (Q37061792) (← links)
• Promoter CpG island methylation markers in colorectal cancer: the road ahead (Q37997086) (← links)
• Association between methylation in mismatch repair genes, V600E BRAF mutation and microsatellite instability in colorectal cancer patients. (Q51449182) (← links)
• KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients. (Q51562493) (← links)
• Combined methylation of p16 and hMLH1 (CMETH2) discriminates a subpopulation with better prognosis in colorectal cancer patients with microsatellite instability tumors. (Q54297781) (← links)
• Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features. (Q54583151) (← links)
• Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis (Q64123101) (← links)
• Clinicopathological Significance of BRAFV600E Mutation in Colorectal Cancer: An Updated Meta-Analysis. (Q64975299) (← links)